Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8. Additionally, a section on HHS Vulnerability Disclosure has been added.SummaryDifference0.8%
- Check12 days agoChange DetectedThe web page has been updated to a new version (v2.16.6) and the previous version (v2.16.5) has been removed. Additionally, a date has been added, indicating a future event on July 18, 2025.SummaryDifference0.9%
- Check19 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check26 days agoChange DetectedThe page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check34 days agoChange DetectedThe date has been updated from May 23, 2025, to June 22, 2025.SummaryDifference0.6%
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference4%
Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.